Conference item
Proteomic evaluation of Pip6a-PMO treatment for myotonic dystrophy type 1
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 48.0KB, Terms of use)
-
- Publisher copy:
- 10.1016/s0960-8966(18)30313-4
Authors
- Publisher:
- Elsevier
- Host title:
- Neuromuscular Disorders
- Journal:
- Neuromuscular Disorders More from this journal
- Volume:
- 28
- Issue:
- Supplement 1
- Pages:
- S8-S9
- Publication date:
- 2018-04-30
- Event location:
- Fitzwilliam College, Cambridge, UK
- DOI:
- EISSN:
-
1873-2364
- ISSN:
-
0960-8966
- Language:
-
English
- Pubs id:
-
pubs:891946
- UUID:
-
uuid:434ea6aa-d2e2-436a-8253-0f9ff7e2f532
- Local pid:
-
pubs:891946
- Source identifiers:
-
891946
- Deposit date:
-
2019-12-04
Terms of use
- Copyright holder:
- Elsevier
- Copyright date:
- 2018
- Notes:
- © 2018 Elsevier B.V. All rights reserved. This paper was presented at the 11th UK Nueromuscular Translational Research Conference, 19-20 April 2018, Cambridge, UK. This is the author accepted manuscript version of the paper. The final version is available from Elsevier at: https://doi.org/10.1016/s0960-8966(18)30313-4
If you are the owner of this record, you can report an update to it here: Report update to this record